Bio Green Med Solution (BGMS) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.60 Bn | 132.75 Bn | 2.84 Bn | 172.72% |
| 2 | Regeneron Pharmaceuticals | 87.04 Bn | 79.04 Bn | 3.93 Bn | 53.21% |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.38 Bn | 53.25 Bn | 52.00 Mn | 47.11% |
| 5 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 75.60% |
| 7 | Alnylam Pharmaceuticals | 35.21 Bn | 31.90 Bn | 992.69 Mn | -100.75% |
| 8 | Royalty Pharma | 28.01 Bn | 27.17 Bn | - | 149.49% |
| 9 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | -104.22% |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 | -48.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.91% |
| Mar 31, 2026 | -143.61% |
| Dec 31, 2025 | -213.62% |
| Sep 30, 2025 | 85.76% |
| Jun 30, 2025 | -74.29% |
| Mar 31, 2025 | 171.00% |
| Dec 31, 2024 | 108.83% |
| Sep 30, 2024 | 24.91% |
| Jun 30, 2024 | 336.36% |
| Mar 31, 2024 | 91.88% |
| Dec 31, 2023 | 43.22% |
| Sep 30, 2023 | 24.83% |
| Jun 30, 2023 | -205.41% |
| Mar 31, 2023 | -1.29% |
| Dec 31, 2022 | -39.93% |
| Sep 30, 2022 | -63.98% |
| Jun 30, 2022 | 89.44% |
| Mar 31, 2022 | -147.58% |
| Dec 31, 2021 | -136.08% |
| Sep 30, 2021 | -48.72% |